Investor profile
Hatteras Venture Partners
Healthcare VC with $900M+ under management across 7 funds.
Directory portfolio
Companies connected here
15
Latest company funding first, including rounds involving other investors. Unknown dates last.
410 Medical
Latest company funding · Jul 14, 2026
LifeFlow rapid fluid infusion devices
Ten63 Therapeutics
Latest company funding · Feb 19, 2026
AI platform for cancer drug discovery
IMMvention Therapeutix
Latest company funding · Dec 23, 2022
Preclinical biotech developing oral small-molecule BACH1 inhibitors for sickle cell disease and other chronic conditions, with its systemic program licensed to Novo Nordisk.
Aer Therapeutics
Latest company funding · —
Biotech developing inhaled therapies that target mucus obstruction in chronic lung disease. Spun out of UCSF.
Altis Biosystems
Latest company funding · —
Intestinal tissue models for drug development
Atsena Therapeutics
Latest company funding · —
Gene therapy for inherited retinal diseases
Cervu Health
Latest company funding · —
Develops a pelvic floor tool and pelvic health system to relieve muscular tension and help women and people with vaginal anatomy regain their pelvic and sexual health.
Contego Medical
Latest company funding · —
Vascular embolic protection devices
Entegrion
Latest company funding · —
Medical-device company developing point-of-care hemostasis diagnostics, including a Viscoelastic Coagulation Monitor.
GeneCentric
Latest company funding · —
Precision-oncology diagnostics company applying gene-expression biology to liquid-biopsy sequencing through its ExpressCT fragmentomics platform and biomarker services.
Incyclix Bio
Latest company funding · —
Selective CDK2 inhibitor developer advancing INX-315 for CDK4/6-resistant ER+/HER2- breast cancer and CCNE1-amplified solid tumors.
InoKare Therapeutics
Latest company funding · —
Small-molecule inhibitors targeting obesity and metabolic disorders
Ribometrix
Latest company funding · —
Small molecule drug discovery platform targeting RNA structures
Thoracic Innovations
Latest company funding · —
Medical device company developing surgical tools for cardiothoracic disease
Tune Therapeutics
Latest company funding · —
Epigenome editing therapeutics for chronic diseases
Portfolio coverage reflects public company-investor links tracked in this directory and may not represent the investor's full portfolio.